Precision Medicine: The New R&D Paradigm

The drug that can be considered the first precision medicine entered the market in 1998, at a time when the concept was referred to as personalized medicine. Herceptin (trastuzumab) was first used for the treatment of a subgroup of breast cancer patients with human epidermal growth factor receptor 2-positive (HER2+) tumors.

Spotlight

Renacon Pharma Ltd.

RENACON PHARMA Limited is the pioneer producer of high-quality powder, solution and cartridge forms of Kidney Dialysis (Hemodialysis) Concentrates since 1997 in Pakistan with ISO 13485, ISO 9001, CE 0120 & GMP certifications through SGS (UK) while FDA (USA) approval is underway. Company has free-sale authorization for Europe as endorsed by MHRA,UK.

OTHER WHITEPAPERS
news image

Defragmenting Data for the Future of Pharma R&D

whitePaper | November 7, 2019

This in-depth paper will show you how to become data agile – tackling both technological issues and solutions, and the cultural and strategic framework needed around this to ensure success.

Read More
news image

The convergence of the pharmaceutical and medicaldevices industries

whitePaper | May 26, 2022

The medical device and pharmaceutical industries each share in a mission to improve health outcomes, from prevention to intervention. As a result of this shared mission, integration and overlap between these two industries has been taking place for decades.

Read More
news image

A Vision for the Global Generic and Biosimilar Medicines Industry

whitePaper | May 22, 2021

One of the key roles of the generic and biosimilar medicines industry is specifically to promote the widest possible access to affordable medicines with high quality, safety, and efficacy for patients globally by introducing competition into the markets. Despite the many hurdles, the generic medicines companies have clearly lived up to the challenges posed by the pandemic as it is an industry that is quick to adapt and agile in manufacturing scale-up. During the outbreak of COVID-19, this industry was providing most of the medicines needed in Intensive Care Units to ventilate critically ill COVID patients. It is also providing most of the quality medicines dispensed around the world, especially for increasingly prevalent chronic diseases and is therefore a strong contributor to health outcomes globally.

Read More
news image

Deck 7 Webinars and Virtual Events

whitePaper | January 1, 2020

If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....

Read More
news image

Sales coaching: preparing for the new reality in pharma

whitePaper | October 14, 2022

COVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an accelerant for progress in its use of digital technology and prompting a reassessment.

Read More
news image

Potential measures to facilitate the productions of activepharmaceutical ingredients (APIs)

whitePaper | March 27, 2023

European countries have been experiencing medicine shortages due to disruptions in the supply chain. Reshoring the productions of active pharmaceutical ingredients (APIs) is considered as an approach to secure the supply.

Read More

Spotlight

Renacon Pharma Ltd.

RENACON PHARMA Limited is the pioneer producer of high-quality powder, solution and cartridge forms of Kidney Dialysis (Hemodialysis) Concentrates since 1997 in Pakistan with ISO 13485, ISO 9001, CE 0120 & GMP certifications through SGS (UK) while FDA (USA) approval is underway. Company has free-sale authorization for Europe as endorsed by MHRA,UK.

Events